Early Events in Herpes Simplex Virus Entry
Early Events in Herpes Simplex Virus Entry
批准号:
8212467
负责人:
Roselyn J Eisenberg
金额:
$37.02万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2013-08-12
关键词:
BackBindingBinding SitesBiochemicalBiologicalBiological AssayBiosensorCaringCell fusionCellsCellular MembraneChemicalsCommon ColdConfocal MicroscopyCoupledDNA VirusesDataDiseaseEncephalitisEventFluorescence Resonance Energy TransferGlycoproteinsGrantHealthHerpes LabialisHerpesviridaeHomologous GeneIndividualKnowledgeLaboratoriesLifeLipidsLiposomesMolecularMonoclonal AntibodiesMovementOpticsPhenotypeProcessProteinsQuartzReceptor CellResearchRoleSimplexvirusSolutionsStructureSurfaceTechniquesTechnologyTimeViralVirionVirusVisualWorkbasehuman diseaseimprovedinnovationinterestmutantnew therapeutic targetnovel strategiesprotein complexreceptorreceptor bindingresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Herpes simplex viruses (HSVs) cause a variety of human diseases, from mild cold sores to more serious ones such as encephalitis. This large DNA virus contains 11 glycoproteins in its envelope, of which 4 are essential for virus entry into susceptible cells, called gB, gD, gH and gL. Virus entry and HSV glycoprotein induced cell-cell fusion involve an interaction of gD with a specific cell receptor, followed by fusion of the envelope with a cellular membrane that requires gB and the gH/gL heterodimer. Whereas gD is present only in alphaherpesviruses, gB and gH/gL homologues are found in all herpesviruses. This application focuses on the processes of HSV entry and HSV glycoprotein-induced cell-cell fusion. Because the C-terminus of the gD ectodomain folds back towards the N-terminus of the native protein, receptor binding sites are hidden. Binding of gD to a receptor therefore requires a conformational change to gD that moves the C-terminus of the gD ectodomain away from the core of gD. This movement and the residues of gD that become exposed somehow trigger next steps of virus-cell and cell-cell fusion carried out by gB and gH/gL. These steps are largely unknown. Structural data show that gB is a viral fusogen, but it only functions in concert with gH/gL. Moreover, although the domain structure of gB is now known, the functions of the individual parts of this complex protein remain to be fully elucidated. My laboratory has constructed mutants of gD, gB and gH that are unable to perform their roles in virus-cell or cell-cell fusion, but the reasons for their null phenotypes are not yet understood. We will use a combination of biochemical, physical chemical, mutational and visual approaches to understand the mechanism by which the four HSV glycoproteins cooperate to carry out virus-cell and cell-cell fusion. State of the art techniques such as liposome flotation, FRET based and fluorescent based assays of lipid mixing (hemifusion) and content mixing (full fusion) will be employed to dissect the phenotypes of the various glycoprotein mutants. We will use optical biosensor (BIAcore) Quartz Crystal Microbalance (Q-sense) technology to examine changes to immobilized intact virions exposed to soluble receptors and monoclonal antibodies under various environmental conditions. We will study heterologous interactions of the quartet of glycoproteins that occur before and during cell-cell fusion using a newly developed assay involving bimolecular complementation of yellow fluorescent protein. This novel approach will be coupled with live cell confocal microscopy to visualize interactions that occur during cell-cell fusion in real time. Two specific aims are proposed: 1) to enhance our understanding of gB structure and function; and 2) to study how the HSV glycoproteins cooperate to accomplish virus-cell and cell-cell fusion. These studies will enhance our understanding of HSV entry, of virus cell fusion in general, and may suggest targets for novel therapeutics. PUBLIC HEALTH RELEVANCE: Herpes simplex virus (HSV) causes many human diseases but the most common are cold sores and encephalitis. The outer surface of the virus contains the proteins that are needed to gain entry into host cells and cause disease and I use molecular biological approaches to understand how these proteins work together to allow the virus to enter host cells. My research may suggest new treatments to stop the virus from gaining entry into its favorite target cells.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Early Events in Herpes Simplex Virus Entry
-
批准号:7462847
-
项目类别:
-
资助金额:$42.68万
-
财政年份:2008
-
负责人:Roselyn J Eisenberg
-
依托单位:
Early Events in Herpes Simplex Virus Entry
-
批准号:8013812
-
项目类别:
-
资助金额:$37.29万
-
财政年份:2008
-
负责人:Roselyn J Eisenberg
-
依托单位:
Early Events in Herpes Simplex Virus Entry
-
批准号:7558236
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2008
-
负责人:Roselyn J Eisenberg
-
依托单位:
Early Events in Herpes Simplex Virus Entry
-
批准号:7760542
-
项目类别:
-
资助金额:$37.44万
-
财政年份:2008
-
负责人:Roselyn J Eisenberg
-
依托单位:
Uncovering the Regulatory Role of gH/gL in HSV Fusion
-
批准号:8038786
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2004
-
负责人:Roselyn J Eisenberg
-
依托单位:
Uncovering the Regulatory Role of gH/gL in HSV Fusion
-
批准号:8581638
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2004
-
负责人:Roselyn J Eisenberg
-
依托单位:
HSV-Receptor Interaction in Entry and Pathogenesis
-
批准号:7010099
-
项目类别:
-
资助金额:$38.69万
-
财政年份:2004
-
负责人:Roselyn J Eisenberg
-
依托单位:
HSV-Receptor Interaction in Entry and Pathogenesis
-
批准号:6776095
-
项目类别:
-
资助金额:$16.22万
-
财政年份:2004
-
负责人:Roselyn J Eisenberg
-
依托单位:
Uncovering the Regulatory Role of gH/gL in HSV Fusion
-
批准号:8389667
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2004
-
负责人:Roselyn J Eisenberg
-
依托单位:
Uncovering the Regulatory Role of gH/gL in HSV Fusion
-
批准号:8769132
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2004
-
负责人:Roselyn J Eisenberg
-
依托单位:
HSV-Receptor Interaction in Entry and Pathogenesis
-
批准号:7172902
-
项目类别:
-
资助金额:$37.57万
-
财政年份:2004
-
负责人:Roselyn J Eisenberg
-
依托单位:
Uncovering the Regulatory Role of gH/gL in HSV Fusion
-
批准号:8197399
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2004
-
负责人:Roselyn J Eisenberg
-
依托单位:
HSV-Receptor Interaction in Entry and Pathogenesis
-
批准号:6846878
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2004
-
负责人:Roselyn J Eisenberg
-
依托单位:
HSV-Receptor Interaction in Entry and Pathogenesis
-
批准号:7342496
-
项目类别:
-
资助金额:$36.86万
-
财政年份:2004
-
负责人:Roselyn J Eisenberg
-
依托单位:
HSV-Receptor Interaction in Entry and Pathogenesis
-
批准号:6673046
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2003
-
负责人:Roselyn J Eisenberg
-
依托单位:
HERPES SIMPLEX VIRUS ENTRY INTO CELLS OF NEURAL ORIGIN
-
批准号:6654638
-
项目类别:
-
资助金额:$10.35万
-
财政年份:2002
-
负责人:Roselyn J Eisenberg
-
依托单位:
HERPES SIMPLEX VIRUS ENTRY INTO CELLS OF NEURAL ORIGIN
-
批准号:6481255
-
项目类别:
-
资助金额:$10.35万
-
财政年份:2001
-
负责人:Roselyn J Eisenberg
-
依托单位:
HERPES SIMPLEX VIRUS ENTRY INTO CELLS OF NEURAL ORIGIN
-
批准号:6324781
-
项目类别:
-
资助金额:$16.89万
-
财政年份:2000
-
负责人:Roselyn J Eisenberg
-
依托单位:
HERPES SIMPLEX VIRUS ENTRY INTO CELLS OF NEURAL ORIGIN
-
批准号:6112415
-
项目类别:
-
资助金额:$16.89万
-
财政年份:1999
-
负责人:Roselyn J Eisenberg
-
依托单位:
HERPES SIMPLEX VIRUS ENTRY INTO CELLS OF NEURAL ORIGIN
-
批准号:6273812
-
项目类别:
-
资助金额:$16.7万
-
财政年份:1998
-
负责人:Roselyn J Eisenberg
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: